ARS Pharmaceuticals, Inc. (SPRY)
4.11
-0.04
(-0.96%)
USD |
NASDAQ |
Sep 18, 16:00
4.19
+0.08
(+1.95%)
After-Hours: 20:00
ARS Pharmaceuticals Price to Book Value : 32.66 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 32.66 |
| September 17, 2026 | 32.98 |
| September 16, 2026 | 33.10 |
| September 15, 2026 | 33.78 |
| September 14, 2026 | 35.76 |
| September 11, 2026 | 37.83 |
| September 10, 2026 | 40.21 |
| September 09, 2026 | 41.56 |
| September 08, 2026 | 42.84 |
| September 04, 2026 | 44.66 |
| September 03, 2026 | 45.06 |
| September 02, 2026 | 46.25 |
| September 01, 2026 | 45.86 |
| August 31, 2026 | 47.68 |
| August 28, 2026 | 46.81 |
| August 27, 2026 | 47.92 |
| August 26, 2026 | 47.92 |
| August 25, 2026 | 45.46 |
| August 24, 2026 | 42.52 |
| August 21, 2026 | 43.75 |
| August 20, 2026 | 43.75 |
| August 19, 2026 | 50.70 |
| August 18, 2026 | 50.07 |
| August 17, 2026 | 49.59 |
| August 14, 2026 | 44.90 |
| Date | Value |
|---|---|
| August 13, 2026 | 48.48 |
| August 12, 2026 | 48.08 |
| August 11, 2026 | 47.29 |
| August 10, 2026 | 46.97 |
| August 07, 2026 | 48.95 |
| August 06, 2026 | 44.11 |
| August 05, 2026 | 42.60 |
| August 04, 2026 | 42.28 |
| August 03, 2026 | 43.39 |
| July 31, 2026 | 40.77 |
| July 30, 2026 | 44.74 |
| July 29, 2026 | 46.33 |
| July 28, 2026 | 45.06 |
| July 27, 2026 | 45.78 |
| July 24, 2026 | 47.21 |
| July 23, 2026 | 47.68 |
| July 22, 2026 | 48.16 |
| July 21, 2026 | 50.54 |
| July 20, 2026 | 51.18 |
| July 17, 2026 | 55.63 |
| July 16, 2026 | 59.29 |
| July 15, 2026 | 60.00 |
| July 14, 2026 | 60.48 |
| July 13, 2026 | 61.51 |
| July 10, 2026 | 63.10 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Capricor Therapeutics, Inc. | 2.138 |
| Passage Bio, Inc. | 3.430 |
| Sionna Therapeutics, Inc. | 1.013 |
| Vertex Pharmaceuticals, Inc. | 6.360 |
| Ardelyx, Inc. | 5.718 |
Price to Book Value Related Metrics
| PS Ratio | 3.484 |
| PEG Ratio | -0.0055 |
| Price | 4.11 |
| Earnings Yield | -52.87% |
| Market Cap | 408.69M |
| PEGY Ratio | -0.0055 |